Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
Beneficial and adverse renal and vascular effects of the vasopeptidase inhibitor omapatrilat in renovascular hypertensive ratsUlrich O Wenzel, Gunter Wolf, Ivonne Jacob, et al.Hypertension (Dallas, Tex. : 1979)|February 21, 2020
B6.Rag1 Knockout Mice Generated at the Jackson Laboratory in 2009 Show a Robust Wild-Type Hypertensive Phenotype in Response to Ang II (Angiotensin II)Anika Seniuk, Jonas L Thiele, Andra Stubbe, et al.American Journal of Physiology. Renal Physiology|February 20, 2009
Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-kappaB p65 signalingCatherine Meyer-Schwesinger, Silke Dehde, Claudia von Ruffer, et al.American Journal of Hypertension|June 27, 2024
Role of the Anaphylatoxin Receptor C5aR2 in Angiotensin II-Induced Hypertension and Hypertensive End-Organ DamageLeonie Dreher, Marlies Bode, Nicolas Ehnert, et al.Journal of Hypertension|September 8, 2023
Increased blood pressure after nonsevere COVID-19Christian Schmidt-Lauber, Elisa Alba Schmidt, Sonja Hänzelmann, et al.American Journal of Physiology. Renal Physiology|April 8, 2016
The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertensionSebastian Weiss, Alva Rosendahl, Daniel Czesla, et al.American Journal of Hypertension|January 20, 2012
CCR5 deficiency does not reduce hypertensive end-organ damage in miceChristian Krebs, Christoph Fraune, Robin Schmidt-Haupt, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|July 22, 2014
Increased expression of (pro)renin receptor does not cause hypertension or cardiac and renal fibrosis in miceAlva Rosendahl, Gianina Niemann, Sascha Lange, et al.Japanese Journal of Radiology|July 14, 2019
Effect of renal denervation procedure on left ventricular mass, myocardial strain and diastolic function by CMR on a 12-month follow-upEnver Tahir, Andreas Koops, Malte L Warncke, et al.British Journal of Pharmacology|April 19, 2023
Complement component C3 as a new target to lower albuminuria in hypertensive kidney diseaseMarlies Bode, Jan Niklas Diemer, The Vinh Luu, et al.Pageof 5